• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IIB型血管性血友病:内源性与输注的大分子多聚体血管性血友病因子的差异清除

Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.

作者信息

Ruggeri Z M, Lombardi R, Gatti L, Bader R, Valsecchi C, Zimmerman T S

出版信息

Blood. 1982 Dec;60(6):1453-6.

PMID:6982737
Abstract

The abnormal multimeric composition of plasma von Willebrand factor in type IIB von Willebrand's disease is transiently corrected after infusion of 1-deamino-[8-D-arginine]-vasopressin. However, the larger multimers released into the circulation disappear more rapidly in these patients than in type I von Willebrand's disease or normals. We demonstrate that the larger multimers of normal von Willebrand factor transfused into a type IIB patient are cleared from the circulation more slowly than multimers of similar size endogenously released from tissue stores. The rate of disappearance of large von Willebrand factor multimers after infusion of cryoprecipitate is similar in IIB, IIA, and severe homozygous-like von Willebrand's disease. Platelets from the IIB patient exhibited normal ristocetin-induced binding of normal von Willebrand factor. However, like normal platelets, they bound IIB von Willebrand factor at lower ristocetin concentrations than required for normal von Willebrand factor. These findings provide evidence that absence of the larger multimers from IIB plasma is related to a molecular abnormality of von Willebrand factor rather than to enhanced affinity of abnormal tissue or cellular binding sites, as is the case in the recently described "pseudo" von Willebrand's disease and "platelet-type" von Willebrand's disease.

摘要

在输注1-去氨基-[8-D-精氨酸]-血管加压素后,IIB型血管性血友病患者血浆中血管性血友病因子异常的多聚体组成会得到短暂纠正。然而,与I型血管性血友病患者或正常人相比,这些患者释放到循环中的较大多聚体消失得更快。我们证明,输注到IIB型患者体内的正常血管性血友病因子的较大多聚体从循环中清除的速度比从组织储存中内源性释放的类似大小的多聚体更慢。在IIB型、IIA型和严重的纯合子样血管性血友病中,输注冷沉淀后大的血管性血友病因子多聚体的消失速率相似。IIB型患者的血小板对正常血管性血友病因子表现出正常的瑞斯托霉素诱导的结合。然而,与正常血小板一样,它们在低于正常血管性血友病因子所需的瑞斯托霉素浓度下结合IIB型血管性血友病因子。这些发现提供了证据,表明IIB型血浆中缺乏较大的多聚体与血管性血友病因子的分子异常有关,而不是与异常组织或细胞结合位点的亲和力增强有关,就像最近描述的“假性”血管性血友病和“血小板型”血管性血友病那样。

相似文献

1
Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.IIB型血管性血友病:内源性与输注的大分子多聚体血管性血友病因子的差异清除
Blood. 1982 Dec;60(6):1453-6.
2
Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.去氨加压素给药后因子VIII/血管性血友病因子的多聚体组成:对血管性血友病各亚型病理生理学和治疗的意义
Blood. 1982 Jun;59(6):1272-8.
3
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.1-去氨基-8-D-精氨酸加压素(DDAVP)诱导的IIB型血管性血友病患者的血小板聚集。
N Engl J Med. 1983 Oct 6;309(14):816-21. doi: 10.1056/NEJM198310063091402.
4
A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.一种可能的双重杂合子II型血管性血友病,瑞斯托霉素诱导的血小板聚集增加。
Am J Hematol. 1992 Jul;40(3):192-8. doi: 10.1002/ajh.2830400307.
5
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).血管性血友病(IIC型)新变体中血管性血友病因子的异常多聚体结构。
J Clin Invest. 1982 Nov;70(5):1124-7. doi: 10.1172/jci110700.
6
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.血管性血友病:通过分析血浆和血小板中因子VIII/血管性血友病因子的多聚体组成来鉴定两种亚型
J Clin Invest. 1980 Jun;65(6):1318-25. doi: 10.1172/JCI109795.
7
The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.通过“中性”单克隆抗体结合试验快速区分IIb型血管性血友病与血小板型(假性)血管性血友病。
Am J Clin Pathol. 1991 Dec;96(6):723-8. doi: 10.1093/ajcp/96.6.723.
8
Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.IIB型血管性血友病中血小板与血管性血友病因子的相互作用
Scand J Haematol. 1985 Sep;35(3):305-14. doi: 10.1111/j.1600-0609.1985.tb01710.x.
9
Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.血管性血友病新亚型中血小板与凝血因子VIII/血管性血友病因子之间的相互作用增强。
N Engl J Med. 1980 May 8;302(19):1047-51. doi: 10.1056/NEJM198005083021902.
10
von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.血管性血友病以瑞斯托霉素敏感性增加和血浆中存在所有血管性血友病因子多聚体为特征。
Blood. 1986 Sep;68(3):668-72.

引用本文的文献

1
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease.VWF 结合适体 rondoraptivon pegol 增加 2B 型血管性血友病患者的血小板计数和 VWF/FVIII。
Blood Adv. 2022 Sep 27;6(18):5467-5476. doi: 10.1182/bloodadvances.2022007805.
2
The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse.异常血管性血友病因子-GPIbα 相互作用对人源化 2B 型血管性血友病模型小鼠巨核细胞生成和血小板的影响。
Haematologica. 2022 Sep 1;107(9):2133-2143. doi: 10.3324/haematol.2021.280561.
3
Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.
血管性血友病的实验室诊断中的危险、问题和进展。
Semin Thromb Hemost. 2014 Feb;40(1):41-8. doi: 10.1055/s-0033-1363166. Epub 2013 Dec 12.
4
Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.在流动血液中,ADAMTS13对血管性血友病因子介导的血小板血栓的大小调节作用
Blood. 2006 Mar 1;107(5):1943-50. doi: 10.1182/blood-2005-07-2972. Epub 2005 Nov 17.
5
Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field.血小板糖蛋白Ibalpha分离的氨基末端结构域在流场中的黏附特性。
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7837-42. doi: 10.1073/pnas.96.14.7837.
6
The von Willebrand-syndrome.血管性血友病综合征
Blut. 1983 Sep;47(3):123-30. doi: 10.1007/BF00320173.
7
Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique.使用改良电泳技术分析因子VIII相关抗原/血管性血友病因子多聚体结构的复杂性。
J Clin Pathol. 1983 Aug;36(8):915-9. doi: 10.1136/jcp.36.8.915.
8
Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.具有正常唾液酸含量的IIB型血管性血友病因子在无瑞斯托菌素的情况下诱导血小板聚集。血小板活化、纤维蛋白原和两种不同膜受体的作用。
J Clin Invest. 1987 Aug;80(2):475-82. doi: 10.1172/JCI113095.
9
Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.纯化的IIA型和IIB型血管性血友病因子与血小板的两个结合位点糖蛋白复合物Ib-IX和IIb-IIIa相互作用时存在明显异常。
J Clin Invest. 1990 Sep;86(3):785-92. doi: 10.1172/JCI114775.
10
Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.IIB型血管性血友病的分子基础。候选突变聚集在血小板糖蛋白Ib结合序列之间的一个二硫键环中。
J Clin Invest. 1991 Apr;87(4):1220-6. doi: 10.1172/JCI115122.